All lobbying filings
The Russell Group, Inc.
The Russell Group, Inc. filed a Q4 report for Novozymes North America Inc. on January 20, 2026, reporting $50,000 in lobbying income.
Lobbying for Novozymes North America Inc. · Biotech company
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
North Carolina
Government bodies contacted
4
Lobbying activity
1
Issues pertaining to biosolutions; issues related to gene editing and biotech regulation; issues related to trade; issues pertaining to biological solutions; issues related to biofuels; issues pertaining to nutrition policy; and issues pertaining to the Farm Bill.